{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:56:25Z","timestamp":1788404185068,"version":"build-2803163510"},"reference-count":128,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Science and Technology Department of Jilin Province","award":["20240305055YY"],"award-info":[{"award-number":["20240305055YY"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-02399-5","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T02:43:12Z","timestamp":1740969792000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effect and mechanism of Dichloroacetate in the treatment of stroke and the resolution strategy for side effect"],"prefix":"10.1186","volume":"30","author":[{"given":"Xu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunshu","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqiao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaihua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dexi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0085-9168","authenticated-orcid":false,"given":"Jinhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,3]]},"reference":[{"issue":"1","key":"2399_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1177\/17474930211065917","volume":"17","author":"VL Feigin","year":"2022","unstructured":"Feigin VL, Brainin M, Norrving B, Martins S, Sacco RL, Hacke W, Fisher M, Pandian J, Lindsay P. World stroke organization (WSO): global stroke fact sheet 2022. Int J Stroke. 2022;17(1):18\u201329. https:\/\/doi.org\/10.1177\/17474930211065917. (Review).","journal-title":"Int J Stroke"},{"key":"2399_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pharmthera.2014.09.003","volume":"146","author":"A Moretti","year":"2015","unstructured":"Moretti A, Ferrari F, Villa RF. Neuroprotection for ischaemic stroke: current status and challenges. Pharmacol Ther. 2015;146:23\u201334. https:\/\/doi.org\/10.1016\/j.pharmthera.2014.09.003. (Review).","journal-title":"Pharmacol Ther"},{"key":"2399_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s13668-024-00568-2","author":"ZL Jia","year":"2024","unstructured":"Jia ZL, Yu XY, Wang X, Li JH. Therapeutic effects of coenzyme q10 in the treatment of ischemic stroke. Curr Nutr Rep. 2024. https:\/\/doi.org\/10.1007\/s13668-024-00568-2. (Review; Early Access).","journal-title":"Curr Nutr Rep"},{"key":"2399_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.yfrne.2018.05.001","volume":"50","author":"L Liberale","year":"2018","unstructured":"Liberale L, Carbone F, Montecucco F, Gebhard C, L\u00fcscher TF, Wegener S, Camici GG. Ischemic stroke across sexes: What is the status quo? Front Neuroendocrinol. 2018;50:3\u201317. https:\/\/doi.org\/10.1016\/j.yfrne.2018.05.001. (Review).","journal-title":"Front Neuroendocrinol"},{"issue":"5","key":"2399_CR5","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/s1474-4422(11)70066-7","volume":"10","author":"R Macrez","year":"2011","unstructured":"Macrez R, Ali C, Toutirais O, Le Mauff B, Defer G, Dirnagl U, Vivien D. Stroke and the immune system: from pathophysiology to new therapeutic strategies. Lancet Neurol. 2011;10(5):471\u201380. https:\/\/doi.org\/10.1016\/s1474-4422(11)70066-7. (Review).","journal-title":"Lancet Neurol"},{"issue":"12","key":"2399_CR6","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.2174\/1570159x18666200528143301","volume":"18","author":"T Okada","year":"2020","unstructured":"Okada T, Suzuki H, Travis ZD, Zhang JH. The stroke-induced blood-brain barrier disruption: current progress of inspection technique, mechanism, and therapeutic target. Curr Neuropharmacol. 2020;18(12):1187\u2013212. https:\/\/doi.org\/10.2174\/1570159x18666200528143301. (Review).","journal-title":"Curr Neuropharmacol"},{"issue":"13\u201314","key":"2399_CR7","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.addr.2008.02.014","volume":"60","author":"PW Stapoole","year":"2008","unstructured":"Stapoole PW, Kurtz TL, Han ZC, Langaee T. Role of dichloroacetate in the treatment of genetic mitochondrial diseases. Adv Drug Deliv Rev. 2008;60(13\u201314):1478\u201387. https:\/\/doi.org\/10.1016\/j.addr.2008.02.014. (Review).","journal-title":"Adv Drug Deliv Rev"},{"issue":"22","key":"2399_CR8","doi-asserted-by":"publisher","first-page":"31708","DOI":"10.18632\/oncotarget.9150","volume":"7","author":"YY Sun","year":"2016","unstructured":"Sun YY, Li T, Xie CC, Zhang YD, Zhou K, Wang XY, Blomgren K, Zhu CL. Dichloroacetate treatment improves mitochondrial metabolism and reduces brain injury in neonatal mice. Oncotarget. 2016;7(22):31708\u201322. https:\/\/doi.org\/10.18632\/oncotarget.9150. (Article).","journal-title":"Oncotarget"},{"issue":"1","key":"2399_CR9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/jnc.12169","volume":"126","author":"R Kochanski","year":"2013","unstructured":"Kochanski R, Peng CY, Higashida T, Geng XK, H\u00fcttemann M, Guthikonda M, Ding YC. Neuroprotection conferred by post-ischemia ethanol therapy in experimental stroke: an inhibitory effect on hyperglycolysis and NADPH oxidase activation. J Neurochem. 2013;126(1):113\u201321. https:\/\/doi.org\/10.1111\/jnc.12169. (Article).","journal-title":"J Neurochem"},{"key":"2399_CR10","doi-asserted-by":"publisher","DOI":"10.34133\/research.0105","author":"HF Ge","year":"2023","unstructured":"Ge HF, Zhou TY, Zhang C, Cun YP, Chen WX, Yang Y, Zhang Q, Li HH, Zhong J, Zhang XY, et al. Targeting ASIC1a Promotes Neural Progenitor Cell Migration and Neurogenesis in Ischemic Stroke. Research. 2023. https:\/\/doi.org\/10.34133\/research.0105. (Article).","journal-title":"Research"},{"issue":"17","key":"2399_CR11","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1021\/acschemneuro.4c00371","volume":"15","author":"J Pu","year":"2024","unstructured":"Pu J, Han J, Yang JH, Yu L, Wan HT. Anaerobic glycolysis and ischemic stroke: from mechanisms and signaling pathways to natural product therapy. ACS Chem Neurosci. 2024;15(17):3090\u2013105. https:\/\/doi.org\/10.1021\/acschemneuro.4c00371. (Review).","journal-title":"ACS Chem Neurosci"},{"issue":"2","key":"2399_CR12","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/00024382-200014020-00022","volume":"14","author":"RW Barbee","year":"2000","unstructured":"Barbee RW, Kline JA, Watts JA. Depletion of lactate by dichloroacetate reduces cardiac efficiency after hemorrhagic shock. Shock. 2000;14(2):208\u201314 (Article).","journal-title":"Shock"},{"key":"2399_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1042\/bj3290191","volume":"329","author":"MM Bowker-Kinley","year":"1998","unstructured":"Bowker-Kinley MM, Davis WI, Wu PF, Harris RA, Popov KM. Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complex. Biochem J. 1998;329:191\u20136. https:\/\/doi.org\/10.1042\/bj3290191. (Article).","journal-title":"Biochem J"},{"issue":"8","key":"2399_CR14","doi-asserted-by":"publisher","first-page":"4879","DOI":"10.1073\/pnas.0831078100","volume":"100","author":"Y Itoh","year":"2003","unstructured":"Itoh Y, Esaki T, Shimoji K, Cook M, Law MJ, Kaufman E, Sokoloff L. Dichloroacetate effects on glucose and lactate oxidation by neurons and astroglia in vitro and on glucose utilization by brain in vivo. Proc Natl Acad Sci USA. 2003;100(8):4879\u201384. https:\/\/doi.org\/10.1073\/pnas.0831078100. (Article).","journal-title":"Proc Natl Acad Sci USA"},{"key":"2399_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/cells8050405","author":"AR Kho","year":"2019","unstructured":"Kho AR, Choi BY, Lee SH, Hong DK, Jeong JH, Kang BS, Kang DH, Park KH, Park JB, Suh SW. The effects of sodium dichloroacetate on mitochondrial dysfunction and neuronal death following hypoglycemia-induced injury. Cells. 2019. https:\/\/doi.org\/10.3390\/cells8050405. (Article).","journal-title":"Cells"},{"issue":"14","key":"2399_CR16","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1007\/s00018-013-1539-2","volume":"71","author":"LR Gray","year":"2014","unstructured":"Gray LR, Tompkins SC, Taylor EB. Regulation of pyruvate metabolism and human disease. Cell Mol Life Sci. 2014;71(14):2577\u2013604. https:\/\/doi.org\/10.1007\/s00018-013-1539-2. (Review).","journal-title":"Cell Mol Life Sci"},{"key":"2399_CR17","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.pharmthera.2016.10.018","volume":"170","author":"MO James","year":"2017","unstructured":"James MO, Jahn SC, Zhong G, Smeltz MG, Hu ZW, Stacpoole PW. Therapeutic applications of dichloroacetate and the role of glutathione transferase zeta-1. Pharmacol Ther. 2017;170:166\u201380. https:\/\/doi.org\/10.1016\/j.pharmthera.2016.10.018. (Review).","journal-title":"Pharmacol Ther"},{"key":"2399_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fnene.2013.00009","volume":"5","author":"TB Rodrigues","year":"2013","unstructured":"Rodrigues TB, Valette J, Bouzier-Sore AK. (13)C NMR spectroscopy applications to brain energy metabolism. Front Neuroenerget. 2013;5:9. https:\/\/doi.org\/10.3389\/fnene.2013.00009. (FromNLM).","journal-title":"Front Neuroenerget"},{"key":"2399_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155570","volume":"129","author":"K Liu","year":"2024","unstructured":"Liu K, Zhou Y, Song X, Zeng J, Wang Z, Wang Z, Zhang H, Xu J, Li W, Gong Z, et al. Baicalin attenuates neuronal damage associated with SDH activation and PDK2-PDH axis dysfunction in early reperfusion. Phytomedicine. 2024;129: 155570. https:\/\/doi.org\/10.1016\/j.phymed.2024.155570. (FromNLM).","journal-title":"Phytomedicine"},{"key":"2399_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-015-0130-0","author":"H Shen","year":"2015","unstructured":"Shen H, Decollogne S, Dilda PJ, Hau E, Chung SA, Luk PP, Hogg PJ, McDonald KL. Dual-targeting of aberrant glucose metabolism in glioblastoma. J Exp Clin Cancer Res. 2015. https:\/\/doi.org\/10.1186\/s13046-015-0130-0. (Article).","journal-title":"J Exp Clin Cancer Res"},{"key":"2399_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112579","author":"SC Xiang","year":"2020","unstructured":"Xiang SC, Huang D, He QL, Li J, Tam KY, Zhang SL, He Y. Development of dual inhibitors targeting pyruvate dehydrogenase kinases and human lactate dehydrogenase A: high-throughput virtual screening, synthesis and biological validation. Eur J Med Chem. 2020. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112579. (Article).","journal-title":"Eur J Med Chem"},{"issue":"48","key":"2399_CR22","doi-asserted-by":"publisher","first-page":"28989","DOI":"10.1074\/jbc.270.48.28989","volume":"270","author":"R Gudi","year":"1995","unstructured":"Gudi R, Bowkerkinley MM, Kedishvili NY, Zhao Y, Popov KM. Diversity of the pyruvate-dehydrogenase kinase gene family in humans. J Biol Chem. 1995;270(48):28989\u201394. https:\/\/doi.org\/10.1074\/jbc.270.48.28989. (Article).","journal-title":"J Biol Chem"},{"key":"2399_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232113240","author":"EH Lee","year":"2022","unstructured":"Lee EH, Chung JW, Sung E, Yoon BH, Jeon M, Park S, Chun SY, Lee JN, Kim BS, Kim HT, et al. Anti-metastatic effect of pyruvate dehydrogenase kinase 4 inhibition in bladder cancer via the ERK, SRC, and JNK Pathways. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms232113240. (Article).","journal-title":"Int J Mol Sci"},{"issue":"16","key":"2399_CR24","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1101\/gad.16771811","volume":"25","author":"AR Grassian","year":"2011","unstructured":"Grassian AR, Metallo CM, Coloff JL, Stephanopoulos G, Brugge JS. Erk regulation of pyruvate dehydrogenase flux through PDK4 modulates cell proliferation. Genes Dev. 2011;25(16):1716\u201333. https:\/\/doi.org\/10.1101\/gad.16771811. (Article).","journal-title":"Genes Dev"},{"key":"2399_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.583217","author":"E Atas","year":"2020","unstructured":"Atas E, Oberhuber M, Kenner L. The implications of PDK1\u20134 on tumor energy metabolism aggressiveness and therapy resistance. Front Oncol. 2020. https:\/\/doi.org\/10.3389\/fonc.2020.583217. (Review).","journal-title":"Front Oncol"},{"issue":"6","key":"2399_CR26","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1097\/shk.0000000000000971","volume":"49","author":"P Wang","year":"2018","unstructured":"Wang P, Chen MD, Yang ZF, Yu T, Zhu J, Zhou LL, Lin JL, Fang XS, Huang ZT, Jiang LY, Tang WC. Activation of pyruvate dehydrogenase activity by dichloroacetate improves survival and neurologic outcomes after cardiac arrest in rats. Shock. 2018;49(6):704\u201311. https:\/\/doi.org\/10.1097\/shk.0000000000000971. (Article).","journal-title":"Shock"},{"issue":"6","key":"2399_CR27","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1111\/j.1471-4159.1989.tb07262.x","volume":"52","author":"Y Katayama","year":"1989","unstructured":"Katayama Y, Welsh FA. Effect of dichloroacetate on regional energy metabolites and pyruvate-dehydrogenase activity during ischemia and reperfusion in gerbil brain. J Neurochem. 1989;52(6):1817\u201322. https:\/\/doi.org\/10.1111\/j.1471-4159.1989.tb07262.x. (Article).","journal-title":"J Neurochem"},{"issue":"1\u20132","key":"2399_CR28","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/0006-8993(91)91383-c","volume":"568","author":"JL Tomsig","year":"1991","unstructured":"Tomsig JL, Gruenstein E, Dimlich RVW. Inhibition of lactate-induced swelling by dichloroacetate in human astrocytoma-cells. Brain Res. 1991;568(1\u20132):92\u2013100. https:\/\/doi.org\/10.1016\/0006-8993(91)91383-c. (Article).","journal-title":"Brain Res"},{"issue":"1","key":"2399_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0304-3940(96)12542-8","volume":"208","author":"J Peeling","year":"1996","unstructured":"Peeling J, Sutherland G, Brown RA, Curry S. Protective effect of dichloroacetate in a rat model of forebrain ischemia. Neurosci Lett. 1996;208(1):21\u20134. https:\/\/doi.org\/10.1016\/0304-3940(96)12542-8. (Article).","journal-title":"Neurosci Lett"},{"issue":"8","key":"2399_CR30","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1002\/jnr.23740","volume":"94","author":"LP Cai","year":"2016","unstructured":"Cai LP, Thibodeau A, Peng CY, Ji XM, Rastogi R, Xin RQ, Singh S, Geng XK, Rafols JA, Ding YC. Combination therapy of normobaric oxygen with hypothermia or ethanol modulates pyruvate dehydrogenase complex in thromboembolic cerebral ischemia. J Neurosci Res. 2016;94(8):749\u201358. https:\/\/doi.org\/10.1002\/jnr.23740. (Article).","journal-title":"J Neurosci Res"},{"key":"2399_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119885","author":"DM Zaher","year":"2021","unstructured":"Zaher DM, Talaat IM, Hussein A, Hachim MY, Omar HA. Differential expression of pyruvate dehydrogenase E1A and its inactive phosphorylated form among breast cancer subtypes. Life Sci. 2021. https:\/\/doi.org\/10.1016\/j.lfs.2021.119885. (Article).","journal-title":"Life Sci"},{"issue":"8","key":"2399_CR32","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1161\/01.Str.23.8.1145119885","volume":"23","author":"RVW Dimlich","year":"1992","unstructured":"Dimlich RVW, Nielsen MM. Facilitating postischemic reduction of cerebral lactate in rats. Stroke. 1992;23(8):1145\u201353. https:\/\/doi.org\/10.1161\/01.Str.23.8.1145119885. (Article).","journal-title":"Stroke"},{"issue":"2","key":"2399_CR33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/bf02736749","volume":"5","author":"RVW Dimlich","year":"1994","unstructured":"Dimlich RVW, Marangos PJ. Dichloroacetate attenuates neuronal damage in a gerbil model of brain ischemia. J Mol Neurosci. 1994;5(2):69\u201381. https:\/\/doi.org\/10.1007\/bf02736749. (Article).","journal-title":"J Mol Neurosci"},{"issue":"3","key":"2399_CR34","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/s0196-0644(87)80175-0","volume":"16","author":"J Kaplan","year":"1987","unstructured":"Kaplan J, Dimlich RVW, Biros MH. Dichloroacetate treatment of ischemic cerebral lactic-acidosis in the fed rat. Ann Emerg Med. 1987;16(3):298\u2013304. https:\/\/doi.org\/10.1016\/s0196-0644(87)80175-0. (Article).","journal-title":"Ann Emerg Med"},{"issue":"4","key":"2399_CR35","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/s0196-0644(86)80174-3","volume":"15","author":"MH Biros","year":"1986","unstructured":"Biros MH, Dimlich RVW, Barsan WG. Postinsult treatment of ischemia-induced cerebral lactic-acidosis in the rat. Ann Emerg Med. 1986;15(4):397\u2013404. https:\/\/doi.org\/10.1016\/s0196-0644(86)80174-3. (Article).","journal-title":"Ann Emerg Med"},{"issue":"1\u20132","key":"2399_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cca.2008.07.016","volume":"397","author":"R Brouns","year":"2008","unstructured":"Brouns R, Sheorajpanday R, Wauters A, De Surgeloose D, Mari\u00ebn P, De Deyn PP. Evaluation of lactate as a marker of metabolic stress and cause of secondary damage in acute ischemic stroke or TIA. Clin Chim Acta. 2008;397(1\u20132):27\u201331. https:\/\/doi.org\/10.1016\/j.cca.2008.07.016. (Article).","journal-title":"Clin Chim Acta"},{"issue":"6","key":"2399_CR37","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1038\/jcbfm.1992.140","volume":"12","author":"LH Chang","year":"1992","unstructured":"Chang LH, Shimizu H, Abiko H, Swanson RA, Faden AI, James TL, Weinstein PR. Effect of dichloroacetate on recovery of brain lactate, phosphorus energy metabolites, and glutamate during reperfusion after complete cerebral-ischemia in rats. J Cerebral Blood Flow Metab. 1992;12(6):1030\u20138. https:\/\/doi.org\/10.1038\/jcbfm.1992.140. (Article).","journal-title":"J Cerebral Blood Flow Metab"},{"issue":"1\u20133","key":"2399_CR38","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00726-001-0133-3","volume":"23","author":"M Balestrino","year":"2002","unstructured":"Balestrino M, Lensman M, Parodi M, Perasso L, Rebaudo R, Melani R, Polenov S, Cupello A. Role of creatine and phosphocreatine in neuronal protection from anoxic and ischemic damage. Amino Acids. 2002;23(1\u20133):221\u20139. https:\/\/doi.org\/10.1007\/s00726-001-0133-3. (Article; Proceedings Paper).","journal-title":"Amino Acids"},{"issue":"8","key":"2399_CR39","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1007\/s00726-016-2173-8","volume":"48","author":"M Balestrino","year":"2016","unstructured":"Balestrino M, Sarocchi M, Adriano E, Spallarossa P. Potential of creatine or phosphocreatine supplementation in cerebrovascular disease and in ischemic heart disease. Amino Acids. 2016;48(8):1955\u201367. https:\/\/doi.org\/10.1007\/s00726-016-2173-8. (Review).","journal-title":"Amino Acids"},{"issue":"11","key":"2399_CR40","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1161\/strokeaha.108.520114","volume":"39","author":"W Yin","year":"2008","unstructured":"Yin W, Signore AP, Iwai M, Cao GD, Gao YQ, Chen J. Rapidly increased neuronal mitochondrial biogenesis after hypoxic-ischemic brain injury. Stroke. 2008;39(11):3057\u201363. https:\/\/doi.org\/10.1161\/strokeaha.108.520114. (Article).","journal-title":"Stroke"},{"issue":"2","key":"2399_CR41","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/sj.emboj.7601963","volume":"27","author":"G Twig","year":"2008","unstructured":"Twig G, Elorza A, Molina AJA, Mohamed H, Wikstrom JD, Walzer G, Stiles L, Haigh SE, Katz S, Las G, et al. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. Embo J. 2008;27(2):433\u201346. https:\/\/doi.org\/10.1038\/sj.emboj.7601963. (Article).","journal-title":"Embo J"},{"key":"2399_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00221","author":"CF Wu","year":"2020","unstructured":"Wu CF, Yao WJ, Kai WW, Liu WK, Wang WE, Li SZ, Chen YC, Wu XY, Wang LF, Li Y, et al. Mitochondrial fusion machinery specifically involved in energy deprivation-induced autophagy. Front Cell Dev Biol. 2020. https:\/\/doi.org\/10.3389\/fcell.2020.00221. (Article).","journal-title":"Front Cell Dev Biol"},{"key":"2399_CR43","doi-asserted-by":"publisher","unstructured":"Xiong, W. J.; Ma, Z.; An, D. Q.; Liu, Z.; Cai, W. Q.; Bai, Y. J.; Zhan, Q.; Lai, W. Y.; Zeng, Q. C.; Ren, H.; Xu, D. L. Mitofusin 2 Participates in Mitophagy and Mitochondrial Fusion Against Angiotensin II-Induced Cardiomyocyte Injury. Frontiers in Physiology 2019, 10, Article. https:\/\/doi.org\/10.3389\/fphys.2019.00411.","DOI":"10.3389\/fphys.2019.00411"},{"issue":"7095","key":"2399_CR44","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nature04723","volume":"441","author":"M Komatsu","year":"2006","unstructured":"Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, Tanida I, Ueno T, Koike M, Uchiyama Y, Kominami E, Tanaka K. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature. 2006;441(7095):880\u20134. https:\/\/doi.org\/10.1038\/nature04723. (Article).","journal-title":"Nature"},{"key":"2399_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2010.33","author":"Q Li","year":"2010","unstructured":"Li Q, Li H, Roughton K, Wang X, Kroemer G, Blomgren K, Zhu C. Lithium reduces apoptosis and autophagy after neonatal hypoxia-ischemia. Cell Death Dis. 2010. https:\/\/doi.org\/10.1038\/cddis.2010.33. (Article).","journal-title":"Cell Death Dis"},{"key":"2399_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112719","author":"T Zhu","year":"2022","unstructured":"Zhu T, Wang L, Wang LP, Wan Q. Therapeutic targets of neuroprotection and neurorestoration in ischemic stroke: applications for natural compounds from medicinal herbs. Biomed Pharmacother. 2022. https:\/\/doi.org\/10.1016\/j.biopha.2022.112719. (Review).","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2399_CR47","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1124\/jpet.116.237503","volume":"360","author":"S Salim","year":"2017","unstructured":"Salim S. Oxidative stress and the central nervous system. J Pharmacol Exp Ther. 2017;360(1):201\u20135. https:\/\/doi.org\/10.1124\/jpet.116.237503. (Review).","journal-title":"J Pharmacol Exp Ther"},{"issue":"20","key":"2399_CR48","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1021\/acschemneuro.3c00456","volume":"14","author":"X Guan","year":"2023","unstructured":"Guan X, Wei DS, Liang ZZ, Xie LY, Wang YF, Huang ZJ, Wu J, Pang T. FDCA attenuates neuroinflammation and brain injury after cerebral ischemic stroke. Acs Chem Neurosci. 2023;14(20):3839\u201354. https:\/\/doi.org\/10.1021\/acschemneuro.3c00456. (Article).","journal-title":"Acs Chem Neurosci"},{"key":"2399_CR49","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5173035","author":"XY Zhao","year":"2021","unstructured":"Zhao XY, Li S, Mo YC, Li RR, Huang SY, Zhang AQ, Ni XQ, Dai QX, Wang JL. DCA protects against oxidation injury attributed to cerebral ischemia-reperfusion by regulating glycolysis through PDK2-PDH-Nrf2 Axis. Oxidat Med Cel Longev. 2021. https:\/\/doi.org\/10.1155\/2021\/5173035. (Article).","journal-title":"Oxidat Med Cel Longev"},{"issue":"8","key":"2399_CR50","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/jat.1356","volume":"28","author":"EA Hassoun","year":"2008","unstructured":"Hassoun EA, Mehta J. Dichloroacetate-induced modulation of cellular antioxidant enzyme activities and glutathione level in the J774A1 cells. J Appl Toxicol. 2008;28(8):931\u20137. https:\/\/doi.org\/10.1002\/jat.1356. (Article).","journal-title":"J Appl Toxicol"},{"key":"2399_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102158","author":"BR Al-Mubarak","year":"2021","unstructured":"Al-Mubarak BR, Bell KFS, Chowdhry S, Meakin PJ, Baxter PS, McKay S, Dando O, Ashford MLJ, Gazaryan I, Hayes JD, Hardingham GE. Non-canonical Keap1-independent activation of Nrf2 in astrocytes by mild oxidative stress. Redox Biol. 2021. https:\/\/doi.org\/10.1016\/j.redox.2021.102158. (Article).","journal-title":"Redox Biol"},{"issue":"1\u20132","key":"2399_CR52","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.brainres.2003.12.031102158","volume":"1003","author":"D M\u00e9thy","year":"2004","unstructured":"M\u00e9thy D, Bertrand N, Prigent-Tessier A, Stanimirovic D, Beley A, Marie C. Differential MnSOD and HO-1 expression in cerebral endothelial cells in response to sublethal oxidative stress. Brain Res. 2004;1003(1\u20132):151\u20138. https:\/\/doi.org\/10.1016\/j.brainres.2003.12.031102158. (Article).","journal-title":"Brain Res"},{"key":"2399_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10101610","author":"R Wufuer","year":"2021","unstructured":"Wufuer R, Fan Z, Liu KL, Zhang YG. Differential yet integral contributions of Nrf1 and Nrf2 in the human HepG2 cells on antioxidant cytoprotective response against tert-butylhydroquinone as a pro-oxidative stressor. Antioxidants. 2021. https:\/\/doi.org\/10.3390\/antiox10101610. (Article).","journal-title":"Antioxidants"},{"issue":"3","key":"2399_CR54","doi-asserted-by":"publisher","first-page":"C452","DOI":"10.1152\/ajpcell.00099.2016","volume":"311","author":"TA Schiffer","year":"2016","unstructured":"Schiffer TA, Peleli M, Sundqvist ML, Ekblom B, Lundberg JO, Weitzberg E, Larsen FJ. Control of human energy expenditure by cytochrome c oxidase subunit IV-2. Am J Physiol Cell Physiol. 2016;311(3):C452\u201361. https:\/\/doi.org\/10.1152\/ajpcell.00099.2016. (Article).","journal-title":"Am J Physiol Cell Physiol"},{"key":"2399_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2016.00056","author":"RJ Turner","year":"2016","unstructured":"Turner RJ, Sharp FR. Implications of MMP9 for blood brain barrier disruption and hemorrhagic transformation following ischemic stroke. Front Cell Neurosci. 2016. https:\/\/doi.org\/10.3389\/fncel.2016.00056. (Review).","journal-title":"Front Cell Neurosci"},{"issue":"9","key":"2399_CR56","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1161\/01.STR.0000177878.33559.fe","volume":"36","author":"CE Hafer-Macko","year":"2005","unstructured":"Hafer-Macko CE, Yu SZ, Ryan AS, Ivey FM, Macko RF. Elevated tumor necrosis factor-\u03b1 in skeletal muscle after stroke. Stroke. 2005;36(9):2021\u20133. https:\/\/doi.org\/10.1161\/01.STR.0000177878.33559.fe. (Article).","journal-title":"Stroke"},{"issue":"2","key":"2399_CR57","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/cns.14041","volume":"29","author":"M Monsour","year":"2023","unstructured":"Monsour M, Croci DM, Agazzi S, Borlongan CV. Contemplating IL-6, a double-edged sword cytokine: Which side to use for stroke pathology? CNS Neurosci Ther. 2023;29(2):493\u20137. https:\/\/doi.org\/10.1111\/cns.14041. (Review).","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"2399_CR58","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s12975-020-00808-x","volume":"12","author":"Y Cai","year":"2021","unstructured":"Cai Y, Xu TT, Lu CQ, Ma YY, Chang D, Zhang Y, Gu XC, Ju SH. Endogenous regulatory T cells promote M2 macrophage phenotype in diabetic stroke as visualized by optical imaging. Transl Stroke Res. 2021;12(1):136\u201346. https:\/\/doi.org\/10.1007\/s12975-020-00808-x. (Article).","journal-title":"Transl Stroke Res"},{"key":"2399_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2023.107132x","author":"DM Zhou","year":"2023","unstructured":"Zhou DM, Chen L, Wang YZ, Gan L, Yuan M, Zhang L, Chen FF. RNA binding protein RPS3 mediates microglial polarization by activating NLRP3 inflammasome via SIRT1 in ischemic stroke. J Stroke Cerebrovasc Dis. 2023. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2023.107132x. (Article).","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2399_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01236","author":"FM Collmann","year":"2019","unstructured":"Collmann FM, Pijnenburg R, Hamzei-Taj S, Minassian A, Folz-Donahue K, Kukat C, Aswendt M, Hoehn M. Individual in vivo profiles of microglia polarization after stroke, represented by the genes iNOS and Ym1. Front Immunol. 2019. https:\/\/doi.org\/10.3389\/fimmu.2019.01236. (Article).","journal-title":"Front Immunol"},{"issue":"3","key":"2399_CR61","doi-asserted-by":"publisher","first-page":"C343","DOI":"10.1152\/ajpcell.00095.2018","volume":"315","author":"W Abdullahi","year":"2018","unstructured":"Abdullahi W, Tripathi D, Ronaldson PT. Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection. Am J Physiol Cell Physiol. 2018;315(3):C343\u201356. https:\/\/doi.org\/10.1152\/ajpcell.00095.2018. (Article).","journal-title":"Am J Physiol Cell Physiol"},{"issue":"4","key":"2399_CR62","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1208\/s12248-017-0091-7","volume":"19","author":"AE Sifat","year":"2017","unstructured":"Sifat AE, Vaidya B, Abbruscato TJ. Blood-brain barrier protection as a therapeutic strategy for acute ischemic stroke. Aaps Journal. 2017;19(4):957\u201372. https:\/\/doi.org\/10.1208\/s12248-017-0091-7. (Review).","journal-title":"Aaps Journal"},{"key":"2399_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.724471","author":"L Zhu","year":"2021","unstructured":"Zhu L, Zhou H, Xu F, Yang HY, Li P, Sheng Y, Liu PH, Kong WM, Liu XA, Yang L, et al. Hepatic ischemia-reperfusion impairs blood-brain barrier partly due to release of arginase from injured liver. Front Pharmacol. 2021. https:\/\/doi.org\/10.3389\/fphar.2021.724471. (Article).","journal-title":"Front Pharmacol"},{"key":"2399_CR64","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.brainres.2012.03.023","volume":"1453","author":"M Ahn","year":"2012","unstructured":"Ahn M, Yang W, Kim H, Jin JK, Moon C, Shin T. Immunohistochemical study of arginase-1 in the spinal cords of Lewis rats with experimental autoimmune encephalomyelitis. Brain Res. 2012;1453:77\u201386. https:\/\/doi.org\/10.1016\/j.brainres.2012.03.023. (Article).","journal-title":"Brain Res"},{"issue":"3","key":"2399_CR65","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.neuroscience.2008.06.025","volume":"158","author":"E Candelario-Jalil","year":"2009","unstructured":"Candelario-Jalil E, Yang Y, Rosenberg GA. Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. Neuroscience. 2009;158(3):983\u201394. https:\/\/doi.org\/10.1016\/j.neuroscience.2008.06.025. (Review).","journal-title":"Neuroscience"},{"key":"2399_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/cells9051313","author":"M Raeeszadeh-Sarmazdeh","year":"2020","unstructured":"Raeeszadeh-Sarmazdeh M, Do LD, Hritz BG. Metalloproteinases and their inhibitors: potential for the development of new therapeutics. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9051313. (Review).","journal-title":"Cells"},{"issue":"6","key":"2399_CR67","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1080\/13813455.2020.1784952","volume":"128","author":"B Zhao","year":"2022","unstructured":"Zhao B, Yin QY, Fei YX, Zhu JP, Qiu YY, Fang WR, Li YM. Research progress of mechanisms for tight junction damage on blood-brain barrier inflammation. Arch Physiol Biochem. 2022;128(6):1579\u201390. https:\/\/doi.org\/10.1080\/13813455.2020.1784952. (Review).","journal-title":"Arch Physiol Biochem"},{"issue":"7","key":"2399_CR68","first-page":"5905","volume":"16","author":"YF Yang","year":"2024","unstructured":"Yang YF, Li CJ, Yang SJ, Zhang Z, Bai X, Tang HM, Huang J. Cepharanthine maintains integrity of the blood-brain barrier (BBB) in stroke via the VEGF\/VEGFR2\/ZO-1 signaling pathway. Aging-Us. 2024;16(7):5905\u201315 (Article).","journal-title":"Aging-Us"},{"key":"2399_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2017.00088","author":"A Becerra-Calixto","year":"2017","unstructured":"Becerra-Calixto A, Cardona-G\u00f3mez GP. The role of astrocytes in neuroprotection after brain stroke: potential in cell therapy. Front Mol Neurosci. 2017. https:\/\/doi.org\/10.3389\/fnmol.2017.00088. (Article).","journal-title":"Front Mol Neurosci"},{"key":"2399_CR70","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.pneurobio.2015.09.008","volume":"144","author":"ZW Liu","year":"2016","unstructured":"Liu ZW, Chopp M. Astrocytes, therapeutic targets for neuroprotection and neurorestoration in ischemic stroke. Progr Neurobiol. 2016;144:103\u201320. https:\/\/doi.org\/10.1016\/j.pneurobio.2015.09.008. (Review).","journal-title":"Progr Neurobiol"},{"key":"2399_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.833431","author":"GY Han","year":"2022","unstructured":"Han GY, Song LJ, Ding ZB, Wang Q, Yan YQ, Huang JJ, Ma CG. The important double-edged role of astrocytes in neurovascular unit after ischemic stroke. Front Aging Neurosci. 2022. https:\/\/doi.org\/10.3389\/fnagi.2022.833431. (Review).","journal-title":"Front Aging Neurosci"},{"key":"2399_CR72","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.expneurol.2013.12.024","volume":"253","author":"JM Cregg","year":"2014","unstructured":"Cregg JM, DePaul MA, Filous AR, Lang BT, Tran A, Silver J. Functional regeneration beyond the glial scar. Exp Neurol. 2014;253:197\u2013207. https:\/\/doi.org\/10.1016\/j.expneurol.2013.12.024. (Review).","journal-title":"Exp Neurol"},{"issue":"1","key":"2399_CR73","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/acel.12530","volume":"16","author":"JC Park","year":"2017","unstructured":"Park JC, Baik SH, Han SH, Cho HJ, Choi H, Kim HJ, Choi H, Lee W, Kim DK, Mook-Jung I. Annexin A1 restores A\u03b2 1\u201342-induced blood-brain barrier disruption through the inhibition of RhoA-ROCK signaling pathway. Aging Cell. 2017;16(1):149\u201361. https:\/\/doi.org\/10.1111\/acel.12530. (Article).","journal-title":"Aging Cell"},{"key":"2399_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23092371","author":"S Feng","year":"2018","unstructured":"Feng S, Zou L, Wang HJ, He R, Liu K, Zhu HF. RhoA\/ROCK-2 pathway inhibition and tight junction protein upregulation by catalpol suppresses lipopolysaccaride-induced disruption of blood-brain barrier permeability. Molecules. 2018. https:\/\/doi.org\/10.3390\/molecules23092371. (Article).","journal-title":"Molecules"},{"issue":"6","key":"2399_CR75","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s11011-021-00709-4","volume":"36","author":"WZ Lu","year":"2021","unstructured":"Lu WZ, Chen ZW, Wen JY. RhoA\/ROCK signaling pathway and astrocytes in ischemic stroke. Metab Brain Dis. 2021;36(6):1101\u20138. https:\/\/doi.org\/10.1007\/s11011-021-00709-4. (Review).","journal-title":"Metab Brain Dis"},{"issue":"11","key":"2399_CR76","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1161\/hs1101.098367","volume":"32","author":"J Chen","year":"2001","unstructured":"Chen J, Sanberg PR, Li Y, Wang L, Lu M, Willing AE, Sanchez-Ramos J, Chopp M. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke. 2001;32(11):2682\u20138. https:\/\/doi.org\/10.1161\/hs1101.098367. (FromNLM).","journal-title":"Stroke"},{"key":"2399_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103047","author":"HL Meng","year":"2021","unstructured":"Meng HL, Fan LZ, Zhang CJ, Zhu LW, Liu PY, Chen J, Bao XY, Pu ZJ, Zhu MS, Xu Y. Synthetic VSMCs induce BBB disruption mediated by MYPT1 in ischemic stroke. Iscience. 2021. https:\/\/doi.org\/10.1016\/j.isci.2021.103047. (Article).","journal-title":"Iscience"},{"key":"2399_CR78","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.neulet.2017.05.059FromNLM","volume":"653","author":"RK Sajja","year":"2017","unstructured":"Sajja RK, Prasad S, Tang S, Kaisar MA, Cucullo L. Blood-brain barrier disruption in diabetic mice is linked to Nrf2 signaling deficits: Role of ABCB10? Neurosci Lett. 2017;653:152\u20138. https:\/\/doi.org\/10.1016\/j.neulet.2017.05.059FromNLM.","journal-title":"Neurosci Lett"},{"key":"2399_CR79","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.nbd.2014.06.005","volume":"70","author":"XP Lu","year":"2014","unstructured":"Lu XP, Chen-Roetling J, Regan RF. Systemic hemin therapy attenuates blood-brain barrier disruption after intracerebral hemorrhage. Neurobiol Dis. 2014;70:245\u201351. https:\/\/doi.org\/10.1016\/j.nbd.2014.06.005. (Article).","journal-title":"Neurobiol Dis"},{"issue":"4\u20135","key":"2399_CR80","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.neuint.2007.10.005","volume":"52","author":"SK Ha","year":"2008","unstructured":"Ha SK, Lee P, Park JA, Oh HR, Lee SY, Park JH, Lee EH, Ryu JH, Lee KR, Kim SY. Apigenin inhibits the production of NO and PGE2 in microglia and inhibits neuronal cell death in a middle cerebral artery occlusion-induced focal ischemia mice model. Neurochem Int. 2008;52(4\u20135):878\u201386. https:\/\/doi.org\/10.1016\/j.neuint.2007.10.005. (FromNLM).","journal-title":"Neurochem Int"},{"issue":"6","key":"2399_CR81","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/00004647-200206000-00001","volume":"22","author":"EA Irving","year":"2002","unstructured":"Irving EA, Bamford M. Role of mitogen- and stress-activated kinases in ischemic injury. J Cereb Blood Flow Metab. 2002;22(6):631\u201347. https:\/\/doi.org\/10.1097\/00004647-200206000-00001. (Review).","journal-title":"J Cereb Blood Flow Metab"},{"issue":"8","key":"2399_CR82","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.bbamcr.2007.03.010","volume":"1773","author":"A Cuenda","year":"2007","unstructured":"Cuenda A, Rousseau S. P38 MAP-Kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta Mol Cell Res. 2007;1773(8):1358\u201375. https:\/\/doi.org\/10.1016\/j.bbamcr.2007.03.010. (Review).","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"1","key":"2399_CR83","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10616-011-9392-3","volume":"64","author":"ZL Chen","year":"2012","unstructured":"Chen ZL, Jiang H, Wan YW, Bi CF, Yuan YA. H2O2-induced secretion of tumor necrosis factor-\u03b1 evokes apoptosis of cardiac myocytes through reactive oxygen species-dependent activation of p38 MAPK. Cytotechnology. 2012;64(1):65\u201373. https:\/\/doi.org\/10.1007\/s10616-011-9392-3. (Article).","journal-title":"Cytotechnology"},{"issue":"1","key":"2399_CR84","doi-asserted-by":"publisher","first-page":"H354","DOI":"10.1152\/ajpheart.00579.2003","volume":"286","author":"WG Zhang","year":"2004","unstructured":"Zhang WG, Li DY, Mehta JL. Role of AIF in human coronary artery endothelial cell apoptosis. Am J Physiol Heart Circ Physiol. 2004;286(1):H354\u20138. https:\/\/doi.org\/10.1152\/ajpheart.00579.2003. (Article).","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"7","key":"2399_CR85","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nrn2665","volume":"10","author":"L Galluzzi","year":"2009","unstructured":"Galluzzi L, Blomgren K, Kroemer G. Mitochondrial membrane permeabilization in neuronal injury. Nat Rev Neurosci. 2009;10(7):481\u201394. https:\/\/doi.org\/10.1038\/nrn2665. (Review).","journal-title":"Nat Rev Neurosci"},{"key":"2399_CR86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131929","author":"Z Jiang","year":"2015","unstructured":"Jiang Z, Watts LT, Huang SL, Shen Q, Rodriguez P, Chen CH, Zhou CM, Duong TQ. The effects of methylene blue on autophagy and apoptosis in mri-defined normal tissue, ischemic penumbra and ischemic core. PLoS ONE. 2015. https:\/\/doi.org\/10.1371\/journal.pone.0131929. (Article).","journal-title":"PLoS ONE"},{"key":"2399_CR87","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2020.613976","author":"L Gan","year":"2021","unstructured":"Gan L, Liao ST, Xing Y, Deng SX. The regulatory functions of lncRNAs on angiogenesis following ischemic stroke. Front Mol Neurosci. 2021. https:\/\/doi.org\/10.3389\/fnmol.2020.613976. (Review).","journal-title":"Front Mol Neurosci"},{"issue":"10","key":"2399_CR88","doi-asserted-by":"publisher","first-page":"8179","DOI":"10.1007\/s12035-016-0270-z","volume":"54","author":"J Liu","year":"2017","unstructured":"Liu J, Li Q, Zhang KS, Hu B, Niu X, Zhou SM, Li SG, Luo YP, Wang Y, Deng ZF. Downregulation of the long non-coding RNA Meg3 promotes angiogenesis after ischemic brain injury by activating notch signaling. Mol Neurobiol. 2017;54(10):8179\u201390. https:\/\/doi.org\/10.1007\/s12035-016-0270-z. (Article).","journal-title":"Mol Neurobiol"},{"key":"2399_CR89","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00523","author":"H Zhao","year":"2019","unstructured":"Zhao H, Mao JQ, Yuan Y, Feng JJ, Cheng H, Fan GR, Zhang YF, Li TJ. Sodium dichloroacetate stimulates angiogenesis by improving endothelial precursor cell function in an AKT\/GSK-3\u03b2\/Nrf2 dependent pathway in vascular dementia rats. Front Pharmacol. 2019. https:\/\/doi.org\/10.3389\/fphar.2019.00523. (Article).","journal-title":"Front Pharmacol"},{"issue":"22","key":"2399_CR90","doi-asserted-by":"publisher","first-page":"11425","DOI":"10.1039\/d2fo02599j","volume":"13","author":"X Wang","year":"2022","unstructured":"Wang X, Li JJ, Zhao DX, Li JH. |Therapeutic and preventive effects of apigenin in cerebral ischemia: a review. Food Funct. 2022;13(22):11425\u201337. https:\/\/doi.org\/10.1039\/d2fo02599j. (Review).","journal-title":"Food Funct"},{"key":"2399_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e08889","author":"Y Katayama","year":"2022","unstructured":"Katayama Y, Kawata Y, Moritoh Y, Watanabe M. Dichloroacetate, a pyruvate dehydrogenase kinase inhibitor, ameliorates type 2 diabetes via reduced gluconeogenesis. Heliyon. 2022. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e08889. (Article).","journal-title":"Heliyon"},{"key":"2399_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10339-5","author":"AU Khan","year":"2017","unstructured":"Khan AU, Allende-Vega N, Gitenay D, Gerbal-Chaloin S, Gondeau C, Vo DN, Belkahla S, Orecchioni S, Talarico G, Bertolini F, et al. The PDK1 inhibitor dichloroacetate controls cholesterol homeostasis through the ERK5\/MEF2 pathway. Sci Rep. 2017. https:\/\/doi.org\/10.1038\/s41598-017-10339-5. (Article).","journal-title":"Sci Rep"},{"issue":"14","key":"2399_CR93","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1016\/j.bmcl.2019.05.006","volume":"29","author":"L Qi","year":"2019","unstructured":"Qi L, Lv T, Cheng YS, Yu M, Han HH, Kong H, Xie WP, Wang H, Zhang YH, Huang ZJ. Fasudil dichloroacetate (FDCA), an orally available agent with potent therapeutic efficiency on monocrotaline-induced pulmonary arterial hypertension rats. Bioorg Med Chem Lett. 2019;29(14):1812\u20138. https:\/\/doi.org\/10.1016\/j.bmcl.2019.05.006. (Article).","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"2399_CR94","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00109-012-0982-0","volume":"91","author":"L Piao","year":"2013","unstructured":"Piao L, Sidhu VK, Fang YH, Ryan JJ, Parikh KS, Hong ZG, Toth PT, Morrow E, Kutty S, Lopaschuk GD, Archer SL. FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate. J Mol Med. 2013;91(3):333\u201346. https:\/\/doi.org\/10.1007\/s00109-012-0982-0. (Article).","journal-title":"J Mol Med"},{"key":"2399_CR95","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.21147\/dddt.S297500","volume":"15","author":"P Liu","year":"2021","unstructured":"Liu P, Huang W, Ding YR, Wu JB, Liang ZZ, Huang ZJ, Xie WP, Kong H. Fasudil dichloroacetate alleviates SU5416\/hypoxia-induced pulmonary arterial hypertension by ameliorating dysfunction of pulmonary arterial smooth muscle cells. Drug Design Dev Ther. 2021;15:1653\u201366. https:\/\/doi.org\/10.21147\/dddt.S297500. (Article).","journal-title":"Drug Design Dev Ther"},{"key":"2399_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-019-0315-2","author":"BK Min","year":"2019","unstructured":"Min BK, Oh CJ, Park S, Lee JM, Go Y, Park BY, Kang HJ, Kim DW, Kim JE, Yoo EK, et al. Therapeutic effect of dichloroacetate against atherosclerosis via hepatic FGF21 induction mediated by acute AMPK activation. Exp Mol Med. 2019. https:\/\/doi.org\/10.1038\/s12276-019-0315-2. (Article).","journal-title":"Exp Mol Med"},{"key":"2399_CR97","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.690371","author":"HJ Hu","year":"2021","unstructured":"Hu HJ, Wang XH, Liu Y, Zhang TQ, Chen ZR, Zhang C, Tang ZH, Qu SL, Tang HF, Jiang ZS. Hydrogen sulfide ameliorates angiotensin ii-induced atrial fibrosis progression to atrial fibrillation through inhibition of the warburg effect and endoplasmic reticulum stress. Front Pharmacol. 2021. https:\/\/doi.org\/10.3389\/fphar.2021.690371. (Article).","journal-title":"Front Pharmacol"},{"issue":"3","key":"2399_CR98","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.bbrc.2019.06.055","volume":"516","author":"HJ Hu","year":"2019","unstructured":"Hu HJ, Zhang C, Tang ZH, Qu SL, Jiang ZS. Regulating the Warburg effect on metabolic stress and myocardial fibrosis remodeling and atrial intracardiac waveform activity induced by atrial fibrillation. Biochem Biophys Res Commun. 2019;516(3):653\u201360. https:\/\/doi.org\/10.1016\/j.bbrc.2019.06.055. (Article).","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"2399_CR99","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1161\/01.Str.17.3.525","volume":"17","author":"ART Colohan","year":"1986","unstructured":"Colohan ART, Welsh FA, Miller ED, Kassell NF. The effect of dichloroacetate on brain lactate levels following incomplete ischemia in the hyperglycemic rat. Stroke. 1986;17(3):525\u20138. https:\/\/doi.org\/10.1161\/01.Str.17.3.525. (Article).","journal-title":"Stroke"},{"issue":"11","key":"2399_CR100","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/s0196-0644(89)80054-x","volume":"18","author":"RVW Dimlich","year":"1989","unstructured":"Dimlich RVW, Timerding BL, Kaplan J, Cammenga R, Vanligten PF. Effects of sodium dichloroacetate dose - brain-metabolites associated with cerebral-ischemia. Ann Emerg Med. 1989;18(11):1172\u201380. https:\/\/doi.org\/10.1016\/s0196-0644(89)80054-x. (Article).","journal-title":"Ann Emerg Med"},{"issue":"3","key":"2399_CR101","first-page":"227","volume":"48","author":"MJ Chandy","year":"2000","unstructured":"Chandy MJ, Ravindra J. Effect of dichloracetate on infarct size in a primate model of focal cerebral ischaemia. Neurol India. 2000;48(3):227\u201330.","journal-title":"Neurol India"},{"issue":"7\u20139","key":"2399_CR102","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1089\/ars.2021.0083","volume":"36","author":"X Gao","year":"2022","unstructured":"Gao X, Gao YY, Yan HY, Liu GJ, Zhou Y, Tao T, Yue TT, Pang C, Chen XX, Gao S, et al. PDK4 decrease neuronal apoptosis via inhibiting ROS-ASK1\/P38 pathway in early brain injury after subarachnoid hemorrhage. Antioxid Redox Signal. 2022;36(7\u20139):505\u201324. https:\/\/doi.org\/10.1089\/ars.2021.0083. (Article).","journal-title":"Antioxid Redox Signal"},{"key":"2399_CR103","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185046","author":"L Piao","year":"2017","unstructured":"Piao L, Fang YH, Kubler MM, Donnino MW, Sharp WW. Enhanced pyruvate dehydrogenase activity improves cardiac outcomes in a murine model of cardiac arrest. PLoS ONE. 2017. https:\/\/doi.org\/10.1371\/journal.pone.0185046. (Article).","journal-title":"PLoS ONE"},{"key":"2399_CR104","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.pneurobio.2017.04.002","volume":"163","author":"HY Li","year":"2018","unstructured":"Li HY, Wu J, Shen HT, Yao XY, Liu CL, Pianta S, Han J, Borlongan CV, Chen G. Autophagy in hemorrhagic stroke: mechanisms and clinical implications. Progr Neurobiol. 2018;163:79\u201397. https:\/\/doi.org\/10.1016\/j.pneurobio.2017.04.002. (Article).","journal-title":"Progr Neurobiol"},{"key":"2399_CR105","doi-asserted-by":"publisher","first-page":"7559","DOI":"10.2147\/ijn.S439728","volume":"18","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Sun MY, Zhao HX, Wang ZY, Shi YA, Dong JX, Wang KF, Wang X, Li XY, Qi HY, Zhao XY. Neuroprotective effects and therapeutic potential of dichloroacetate: targeting metabolic disorders in nervous system diseases. Int J Nanomed. 2023;18:7559\u201381. https:\/\/doi.org\/10.2147\/ijn.S439728. (Review).","journal-title":"Int J Nanomed"},{"issue":"11","key":"2399_CR106","first-page":"1134","volume":"26","author":"MO James","year":"1998","unstructured":"James MO, Yan ZM, Cornett R, Jayanti V, Henderson GN, Davydova N, Katovich MJ, Pollock B, Stacpoole PW. Pharmacokinetics and metabolism of 14C dichloroacetate in male Sprague-Dawley rats: identification of glycine conjugates, including hippurate, as urinary metabolites of dichloroacetate. Drug Metab Dispos. 1998;26(11):1134\u201343 (Article).","journal-title":"Drug Metab Dispos"},{"issue":"10","key":"2399_CR107","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1203\/00006450-198418100-00005","volume":"18","author":"Y Kuroda","year":"1984","unstructured":"Kuroda Y, Toshima K, Watanabe T, Kobashi H, Ito M, Takeda E, Miyao M. Effects of dichloroacetate on pyruvate metabolism in rat-brain invivo. Pediatr Res. 1984;18(10):936\u20138. https:\/\/doi.org\/10.1203\/00006450-198418100-00005. (Article).","journal-title":"Pediatr Res"},{"issue":"1","key":"2399_CR108","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/15287399309531697","volume":"38","author":"ELC Lin","year":"1993","unstructured":"Lin ELC, Mattox JK, Daniel FB. Tissue distribution, excretion, and urinary metabolites of dichloroacetic acid in the male fischer 344 rat. J Toxicol Environ Health. 1993;38(1):19\u201332. https:\/\/doi.org\/10.1080\/15287399309531697. (Article).","journal-title":"J Toxicol Environ Health"},{"issue":"3","key":"2399_CR109","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1124\/jpet.107.134593","volume":"324","author":"AL Shroads","year":"2008","unstructured":"Shroads AL, Guo X, Dixit V, Liu HP, James MO, Stacpoole PW. Age-dependent kinetics and metabolism of dichloroacetate: Possible relevance to toxicity. J Pharmacol Exp Ther. 2008;324(3):1163\u201371. https:\/\/doi.org\/10.1124\/jpet.107.134593. (Article).","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"2399_CR110","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1289\/ehp.02110757","volume":"110","author":"SA Saghir","year":"2002","unstructured":"Saghir SA, Schultz IR. Low-dose pharmacokinetics and oral bioavailability of dichloroacetate in naive and GST-zeta-depleted rats. Environ Health Perspect. 2002;110(8):757\u201363. https:\/\/doi.org\/10.1289\/ehp.02110757. (FromNLM).","journal-title":"Environ Health Perspect"},{"issue":"6","key":"2399_CR111","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1124\/dmd.30.6.616","volume":"30","author":"HB Lantum","year":"2002","unstructured":"Lantum HB, Baggs RB, Krenitsky DM, Board PG, Anders MW. Immunohistochemical localization and activity of glutathione transferase zeta (GSTZ1\u20131) in rat tissues. Drug Metab Disposit. 2002;30(6):616\u201325. https:\/\/doi.org\/10.1124\/dmd.30.6.616. (Article).","journal-title":"Drug Metab Disposit"},{"issue":"2","key":"2399_CR112","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/bf00421855","volume":"19","author":"PG Wells","year":"1980","unstructured":"Wells PG, Moore GW, Rabin D, Wilkinson GR, Oates JA, Stacpoole PW. Metabolic effects and pharmacokinetics of intravenously administered dichloroacetate in humans. Diabetologia. 1980;19(2):109\u201313. https:\/\/doi.org\/10.1007\/bf00421855. (Article).","journal-title":"Diabetologia"},{"issue":"12","key":"2399_CR113","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1021\/tx990085l","volume":"12","author":"WB Anderson","year":"1999","unstructured":"Anderson WB, Board PG, Gargano B, Anders MW. Inactivation of glutathione transferase zeta by dichloroacetic acid and other fluorine-lacking \u03b1-haloalkanoic acids. Chem Res Toxicol. 1999;12(12):1144\u20139. https:\/\/doi.org\/10.1021\/tx990085l. (Article).","journal-title":"Chem Res Toxicol"},{"issue":"3","key":"2399_CR114","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s10637-013-0047-4","volume":"32","author":"EM Dunbar","year":"2014","unstructured":"Dunbar EM, Coats BS, Shroads AL, Langaee T, Lew A, Forder JR, Shuster JJ, Wagner DA. Phase 1 trial of dichloroacetate (DCA) in adults with recurrent malignant brain tumors. Invest New Drugs. 2014;32(3):452\u201364. https:\/\/doi.org\/10.1007\/s10637-013-0047-4. (Article).","journal-title":"Invest New Drugs"},{"issue":"4","key":"2399_CR115","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s11011-020-00657-5","volume":"36","author":"W Wei","year":"2021","unstructured":"Wei W, Dong Q, Jiang W, Wang Y, Chen Y, Han T, Sun C. Dichloroacetic acid-induced dysfunction in rat hippocampus and the protective effect of curcumin. Metab Brain Dis. 2021;36(4):545\u201356. https:\/\/doi.org\/10.1007\/s11011-020-00657-5. (Article).","journal-title":"Metab Brain Dis"},{"issue":"6","key":"2399_CR116","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/s0892-0362(99)00029-x","volume":"21","author":"VC Moser","year":"1999","unstructured":"Moser VC, Phillips PM, McDaniel KL, MacPhail RC. Behavioral evaluation of the neurotoxicity produced by dichloroacetic acid in rats. Neurotoxicol Teratol. 1999;21(6):719\u201331. https:\/\/doi.org\/10.1016\/s0892-0362(99)00029-x. (FromNLM).","journal-title":"Neurotoxicol Teratol"},{"key":"2399_CR117","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1801","author":"Y Wang","year":"2020","unstructured":"Wang Y, Jiang W, Dong Q, Zhao Y, Chen Y, Sun C, Sun G. Fetal exposure to dichloroacetic acid and impaired cognitive function in the adulthood. Brain Behav. 2020. https:\/\/doi.org\/10.1002\/brb3.1801. (Article).","journal-title":"Brain Behav"},{"issue":"3","key":"2399_CR118","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/CAD.0b013e3283425888","volume":"22","author":"A Kagiava","year":"2011","unstructured":"Kagiava A, Theophilidis G. High concentrations of dichloroacetate have minor effects on the vitality of the mammalian nerve fibers: an ex-vivo electrophysiological study. Anticancer Drugs. 2011;22(3):273\u20136. https:\/\/doi.org\/10.1097\/CAD.0b013e3283425888. (Article).","journal-title":"Anticancer Drugs"},{"issue":"9","key":"2399_CR119","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1097\/NEN.0b013e3181b40217","volume":"68","author":"NA Calcutt","year":"2009","unstructured":"Calcutt NA, Lopez VL, Bautista AD, Mizisin LM, Torres BR, Shroads AL, Mizisin AP, Stacpoole PW. Peripheral neuropathy in rats exposed to dichloroacetate. J Neuropathol Exp Neurol. 2009;68(9):985\u201393. https:\/\/doi.org\/10.1097\/NEN.0b013e3181b40217. (Article).","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"2399_CR120","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.braindev.2011.03.003","volume":"34","author":"Y Koga","year":"2012","unstructured":"Koga Y, Povalko N, Katayama K, Kakimoto N, Matsuishi T, Naito E, Tanaka M. Beneficial effect of pyruvate therapy on Leigh syndrome due to a novel mutation in PDH E1\u03b1 gene. Brain Dev. 2012;34(2):87\u201391. https:\/\/doi.org\/10.1016\/j.braindev.2011.03.003. (Article).","journal-title":"Brain Dev"},{"issue":"2","key":"2399_CR121","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ymgme.2013.03.019","volume":"109","author":"M Abdelmalak","year":"2013","unstructured":"Abdelmalak M, Lew A, Ramezani R, Shroads AL, Coats BS, Langaee T, Shankar MN, Neiberger RE, Subramony SH, Stacpoole PW. Long-term safety of dichloroacetate in congenital lactic acidosis. Mol Genet Metab. 2013;109(2):139\u201343. https:\/\/doi.org\/10.1016\/j.ymgme.2013.03.019. (Article).","journal-title":"Mol Genet Metab"},{"issue":"5","key":"2399_CR122","doi-asserted-by":"publisher","first-page":"E1223","DOI":"10.1542\/peds.2007-2062","volume":"121","author":"PW Stacpoole","year":"2008","unstructured":"Stacpoole PW, Gilbert LR, Neiberger RE, Carney PR, Valenstein E, Theriaque DW, Shuster JJ. Evaluation of long-term treatment of children with congenital lactic acidosis with dichloroacetate. Pediatrics. 2008;121(5):E1223\u20138. https:\/\/doi.org\/10.1542\/peds.2007-2062. (Article).","journal-title":"Pediatrics"},{"issue":"2","key":"2399_CR123","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/toxsci\/kfx146","volume":"159","author":"LC Wehmas","year":"2017","unstructured":"Wehmas LC, DeAngelo AB, Hester SD, Chorley BN, Carswell G, Olson GR, George MH, Carter JH, Eldridge SR, Fisher A, Vallanat B, et al. Metabolic disruption early in life is associated with latent carcinogenic activity of dichloroacetic acid in mice. Toxicol Sci. 2017;159(2):354\u201365. https:\/\/doi.org\/10.1093\/toxsci\/kfx146. (Article).","journal-title":"Toxicol Sci"},{"issue":"3","key":"2399_CR124","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1212\/01.wnl.0000196641.05913.27","volume":"66","author":"P Kaufmann","year":"2006","unstructured":"Kaufmann P, Engelstad K, Wei Y, Jhung S, Sano MC, Shungu DC, Millar WS, Hong X, Gooch CL, Mao X, et al. Dichloroacetate causes toxic neuropathy in MELAS\u2014a randomized, controlled clinical trial. Neurology. 2006;66(3):324\u201330. https:\/\/doi.org\/10.1212\/01.wnl.0000196641.05913.27.","journal-title":"Neurology"},{"key":"2399_CR125","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2017.00233","author":"ZJ Liu","year":"2017","unstructured":"Liu ZJ, Ran YY, Huang S, Wen SH, Zhang WX, Liu XR, Ji ZL, Geng XK, Ji XM, Du HS, et al. Curcumin Protects against Ischemic Stroke by Titrating Microglia\/Macrophage Polarization. Front Aging Neurosci. 2017. https:\/\/doi.org\/10.3389\/fnagi.2017.00233. (Article).","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"2399_CR126","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1085-9489.2006.00078.x","volume":"11","author":"G Cavaletti","year":"2006","unstructured":"Cavaletti G, Jann S, Pace A, Plasmati R, Siciliano G, Briani C, Cocito D, Padua L, Ghiglione E, Manicone M, Giussani G. Multi-center assessment of the Total Neuropathy Score for chemotherapy-induced peripheral neurotoxicity. JPNS. 2006;11(2):135\u201341. https:\/\/doi.org\/10.1111\/j.1085-9489.2006.00078.x. (FromNLM).","journal-title":"JPNS"},{"key":"2399_CR127","unstructured":"National Toxicology, P. RoC Monograph Series. In: report on carcinogens monograph on haloacetic acids found as water disinfection by-products: RoC monograph 12, National Toxicology Program, 2018."},{"issue":"2","key":"2399_CR128","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ymgme.2013.03.019FromNLM","volume":"109","author":"M Abdelmalak","year":"2013","unstructured":"Abdelmalak M, Lew A, Ramezani R, Shroads AL, Coats BS, Langaee T, Shankar MN, Neiberger RE, Subramony SH, Stacpoole PW. Long-term safety of dichloroacetate in congenital lactic acidosis. Mol Genet Metab. 2013;109(2):139\u201343. https:\/\/doi.org\/10.1016\/j.ymgme.2013.03.019FromNLM.","journal-title":"Mol Genet Metab"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02399-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02399-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02399-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T14:30:00Z","timestamp":1741012200000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02399-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":128,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2399"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02399-5","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,3]]},"assertion":[{"value":"30 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"148"}}